4th Quarter - Report

THE DUBERSTEIN GROUP INC. for PHRMA INC.

Firm
Client
Income
$75,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

21st Century Cures - HR 6, 21st Century Cures Act (Upton/DeGette; HR 34-21st Century Cures Act

LobbyistCovered position, as disclosed
KENNETH DUBERSTEIN —
DANIEL P MEYER —
DAVID J SCHIAPPA —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 6 (114th), H.R. 34 (114th)

Medicare/Medicaid MMM

Center for Medicare and Medicaid drug demonstration project, executive action.

LobbyistCovered position, as disclosed
BRIAN GRIFFIN —
DANIEL P MEYER —
ANNE WALL New Legislative Correspondent/Floor Assistant/Office Counsel/Floor Director-Ofc of Sen. Durbin; Spec Asst/Dep. Asst to President, Ofc Leg Affairs, The White House; Counselor to the Sec Treasury; Asst. Sec Leg Affairs, Dept. Treasury

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Budget/Appropriations BUD

Budget and government funding issues, HR 2028-Further Continuing and Security Assistance Appropriations Act, 2017

LobbyistCovered position, as disclosed
DAVID J SCHIAPPA —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 2028 (114th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.